These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Steinberg KP Crit Care Med; 2002 Jun; 30(6 Suppl):S362-4. PubMed ID: 12072662 [TBL] [Abstract][Full Text] [Related]
4. Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients : a randomized, double-blind, placebo-controlled study. Gursoy O; Memiş D; Sut N Clin Drug Investig; 2008; 28(12):777-82. PubMed ID: 18991471 [TBL] [Abstract][Full Text] [Related]
5. The comparison of extemporaneous preparations of omeprazole, pantoprazole oral suspension and intravenous pantoprazole on the gastric pH of critically ill-patients. Dabiri Y; Fahimi F; Jamaati H; Hashemian SM Indian J Crit Care Med; 2015 Jan; 19(1):21-6. PubMed ID: 25624646 [TBL] [Abstract][Full Text] [Related]
6. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients. Jung R; MacLaren R Ann Pharmacother; 2002 Dec; 36(12):1929-37. PubMed ID: 12452757 [TBL] [Abstract][Full Text] [Related]
7. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis. Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D; Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708 [TBL] [Abstract][Full Text] [Related]
8. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194 [TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous application of esomeprazole 40 mg versus pantoprazole 40 mg on 24-hour intragastric pH in healthy adults. Hartmann D; Eickhoff A; Damian U; Riemann JF; Schilling D Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):133-7. PubMed ID: 17272998 [TBL] [Abstract][Full Text] [Related]
10. A possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in rats. Lee HJ; Han YM; Kim EH; Kim YJ; Hahm KB BMC Gastroenterol; 2012 Oct; 12():143. PubMed ID: 23066659 [TBL] [Abstract][Full Text] [Related]
11. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. Somberg L; Morris J; Fantus R; Graepel J; Field BG; Lynn R; Karlstadt R J Trauma; 2008 May; 64(5):1202-10. PubMed ID: 18469642 [TBL] [Abstract][Full Text] [Related]
12. Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages. Metz DC; Amer F; Hunt B; Vakily M; Kukulka MJ; Samra N Aliment Pharmacol Ther; 2006 Apr; 23(7):985-95. PubMed ID: 16573801 [TBL] [Abstract][Full Text] [Related]
13. Preventing the gastrointestinal consequences of stress-related mucosal disease. Metz DC Curr Med Res Opin; 2005 Jan; 21(1):11-8. PubMed ID: 15881471 [TBL] [Abstract][Full Text] [Related]
14. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs. Bersenas AM; Mathews KA; Allen DG; Conlon PD Am J Vet Res; 2005 Mar; 66(3):425-31. PubMed ID: 15822586 [TBL] [Abstract][Full Text] [Related]
15. Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill. More DG; Raper RF; Munro IA; Watson CJ; Boutagy JS; Shenfield GM Surgery; 1985 Feb; 97(2):215-24. PubMed ID: 3881838 [TBL] [Abstract][Full Text] [Related]
16. BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS. Foroutan N; Fahimi F; Dabiri Y; Foroutan A; Habibi M; Salamzadeh J J Popul Ther Clin Pharmacol; 2015 Dec; 22(3):e292-e302. PubMed ID: 28414416 [TBL] [Abstract][Full Text] [Related]
17. Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers. Hung WK; Li VK; Chung CK; Ying MW; Loo CK; Liu CK; Lam BY; Chan MC ANZ J Surg; 2007 Aug; 77(8):677-81. PubMed ID: 17635283 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs. Kuhl A; Odunayo A; Price J; Hecht S; Marshall K; Steiner J; Tolbert MK J Vet Intern Med; 2020 Mar; 34(2):678-683. PubMed ID: 32020689 [TBL] [Abstract][Full Text] [Related]
19. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936 [TBL] [Abstract][Full Text] [Related]